Lv1
64 积分 2022-10-17 加入
Acute lymphoblastic leukaemia presenting as chronic recurrent multifocal osteomyelitis
16小时前
求助中
Glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing CAR-T cell therapy: a phase 2 LYSA study
29天前
已完结
Sequential CAR T-cell therapy in myeloma: going from BCMA to GPRC5D
1个月前
已关闭
Anti-GPRC5D CAR T-cell therapy as a salvage treatment in patients with progressive multiple myeloma after anti-BCMA CAR T-cell therapy: a single-centre, single-arm, phase 2 trial
1个月前
已完结
Nanobody-based naturally selected CD7-targeted CAR-T therapy for acute myeloid leukemia
2个月前
已关闭
A First-in-Class JAK/ROCK Inhibitor, Rovadicitinib, for Glucocorticoid-Refractory or -Dependent Chronic GVHD
2个月前
已关闭
A real-world experience of efficacy and safety of belantamab mafodotin in relapsed refractory multiple myeloma
3个月前
已完结
Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma
3个月前
已完结
皖公网安备34019202002308
